| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
A first in human study of SB-743921, a kinesin spindle protein inhibitor, to determine pharmacokinetics, biologic effects and establish a recommended phase II dose
|
Holen, Kyle D.
|
|
2010
|
67 |
2 |
p. 447-454
|
artikel
|
| 2 |
Announcement
|
|
|
2011
|
67 |
2 |
p. 247
|
artikel
|
| 3 |
A novel bis-indole destabilizes microtubules and displays potent in vitro and in vivo antitumor activity in prostate cancer
|
Ahn, Sunjoo
|
|
2010
|
67 |
2 |
p. 293-304
|
artikel
|
| 4 |
A phase I/II trial of the oral antiangiogenic agent TSU-68 in patients with advanced hepatocellular carcinoma
|
Kanai, Fumihiko
|
|
2010
|
67 |
2 |
p. 315-324
|
artikel
|
| 5 |
A phase I study of bevacizumab (B) in combination with everolimus (E) and erlotinib (E) in advanced cancer (BEE)
|
Bullock, Karen E.
|
|
2010
|
67 |
2 |
p. 465-474
|
artikel
|
| 6 |
A phase I study of OSI-461 in combination with mitoxantrone in patients with advanced solid tumors potentially responsive to mitoxantrone
|
Resta, Lee P.
|
|
2010
|
67 |
2 |
p. 431-438
|
artikel
|
| 7 |
Cetuximab and circadian chronomodulated chemotherapy as salvage treatment for metastatic colorectal cancer (mCRC): safety, efficacy and improved secondary surgical resectability
|
Lévi, Francis
|
|
2010
|
67 |
2 |
p. 339-348
|
artikel
|
| 8 |
Chemotherapeutic activity of silymarin combined with doxorubicin or paclitaxel in sensitive and multidrug-resistant colon cancer cells
|
Colombo, Valentina
|
|
2010
|
67 |
2 |
p. 369-379
|
artikel
|
| 9 |
Clinical effect of erlotinib as first-line treatment for Asian elderly patients with advanced non-small-cell lung cancer
|
Xu, Xin-Hua
|
|
2010
|
67 |
2 |
p. 475-479
|
artikel
|
| 10 |
Combination effects of platinum drugs and N1, N11 diethylnorspermine on spermidine/spermine N1-acetyltransferase, polyamines and growth inhibition in A2780 human ovarian carcinoma cells and their oxaliplatin and cisplatin-resistant variants
|
Tummala, Ramakumar
|
|
2010
|
67 |
2 |
p. 401-414
|
artikel
|
| 11 |
Histone deacetylase inhibitor (HDACI) PCI-24781 potentiates cytotoxic effects of doxorubicin in bone sarcoma cells
|
Yang, Cao
|
|
2010
|
67 |
2 |
p. 439-446
|
artikel
|
| 12 |
In vitro anti-mesothelioma activity of cisplatin–gemcitabine combinations: evidence for sequence-dependent effects
|
Zanellato, Ilaria
|
|
2010
|
67 |
2 |
p. 265-273
|
artikel
|
| 13 |
Mechanistic study of BNP7787-mediated cisplatin nephroprotection: modulation of human aminopeptidase N
|
Hausheer, F. H.
|
|
2010
|
67 |
2 |
p. 381-391
|
artikel
|
| 14 |
Pharmacokinetics and pharmacodynamics of AZD6244 (ARRY-142886) in tumor-bearing nude mice
|
Denton, Cathrine L.
|
|
2010
|
67 |
2 |
p. 349-360
|
artikel
|
| 15 |
Pharmacokinetics in mice and metabolism in murine and human liver fractions of the putative cancer chemopreventive agents 3′,4′,5′,5,7-pentamethoxyflavone and tricin (4′,5,7-trihydroxy-3′,5′-dimethoxyflavone)
|
Cai, Hong
|
|
2010
|
67 |
2 |
p. 255-263
|
artikel
|
| 16 |
Phase I and pharmacokinetic study of lonafarnib, SCH 66336, using a 2-week on, 2-week off schedule in patients with advanced solid tumors
|
Castaneda, Carlos
|
|
2010
|
67 |
2 |
p. 455-463
|
artikel
|
| 17 |
Phase I dose escalation study of MK-0457, a novel Aurora kinase inhibitor, in adult patients with advanced solid tumors
|
Traynor, Anne M.
|
|
2010
|
67 |
2 |
p. 305-314
|
artikel
|
| 18 |
Phase II study of S-1 in patients with gemcitabine-resistant advanced pancreatic cancer
|
Sudo, Kentaro
|
|
2010
|
67 |
2 |
p. 249-254
|
artikel
|
| 19 |
Phase I study of the combination of nedaplatin and gemcitabine in previously untreated advanced squamous cell lung cancer
|
Masago, Katsuhiro
|
|
2010
|
67 |
2 |
p. 325-330
|
artikel
|
| 20 |
Plasma pharmacokinetics and oral bioavailability of the 3,4,5,6-tetrahydrouridine (THU) prodrug, triacetyl-THU (taTHU), in mice
|
Beumer, Jan H.
|
|
2010
|
67 |
2 |
p. 421-430
|
artikel
|
| 21 |
Population pharmacokinetics of 3-aminopyridine-2-carboxaldehyde thiosemicarbazone (Triapine®) in cancer patients
|
Kolesar, Jill
|
|
2010
|
67 |
2 |
p. 393-400
|
artikel
|
| 22 |
Risk factors contributing to the development of carboplatin-related delayed hypersensitivity reactions in Japanese patients with gynecologic cancers
|
Sugimoto, Hiroko
|
|
2010
|
67 |
2 |
p. 415-419
|
artikel
|
| 23 |
Schedule treatment design and quantitative in vitro evaluation of chemotherapeutic combinations for metastatic prostate cancer therapy
|
Pinto, Ana Catarina
|
|
2010
|
67 |
2 |
p. 275-284
|
artikel
|
| 24 |
Second-line chemotherapy with Capecitabine (Xeloda) and Docetaxel (Taxotere) in previously treated, unresectable adenocarcinoma of pancreas: the final results of a phase II trial
|
Katopodis, Ourania
|
|
2010
|
67 |
2 |
p. 361-368
|
artikel
|
| 25 |
Serum levels of surfactant protein D predict the anti-tumor activity of gefitinib in patients with advanced non-small cell lung cancer
|
Yamaguchi, Hiroyuki
|
|
2010
|
67 |
2 |
p. 331-338
|
artikel
|
| 26 |
Tamoxifen and raloxifene suppress the proliferation of estrogen receptor-negative cells through inhibition of glutamine uptake
|
Todorova, Valentina K.
|
|
2010
|
67 |
2 |
p. 285-291
|
artikel
|
| 27 |
The role of K-Ras gene mutation in TRAIL-induced apoptosis in pancreatic and lung cancer cell lines
|
Sahu, Ravi P.
|
|
2010
|
67 |
2 |
p. 481-487
|
artikel
|
Tijdschrift beschrijving